Oncology

Image

Global Wilms Tumor Market - Industry Trends and Forecast to 2028

  • Oncology
  • Upcoming Report
  • Feb 2021
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Wilms Tumor Market, By Types (Favourable histology and Anaplastic histology), Stages (Stage I, Stage II, Stage III, Stage III, Stage IV and Stage V), Diagnosis (Physical Examination, Imaging Tests, and Lab Tests), Treatment (Surgery, Chemotherapy and Radiation Therapy), End-User (Cancer Research Institutes, Diagnostic Laboratories, Hospitals, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028

Wilms Tumor Market Market Analysis and Insights : Global Wilms Tumor Market

The wilms tumor market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 4.30% in the above-mentioned research forecast period. Ongoing research and products under clinical trials are the factors for the growth of the wilms tumor market.  

Wimls tumor (WT) also known as nephroblastoma is considered as one of the rare kidney cancer that mainly affects the children. It mainly affects the children with age group of 3 to 4 years and is rare in children whose age is more than 5 years. WT occurs mainly in one kidney and rarely found in both kidneys (5-10%). The WT in adults are rare having incidence rate of less than 0.2 cases per million per year. Only 3% of adult patients suffer from WT. Symptoms for the WT are abdominal mass, abdominal pain and swelling. Other symptoms include fever, nausea, blood in urine, high blood pressure and may others. The cause for WT is unclear but some reports say that environmental toxic materials and history background (1.5%) may be the cause for WT. Children with wilms tumor-aniridia-genitourinary malformation-retardation syndrome, beckwith-Wiedemann syndrome and denys-drash syndrome are at high risk for WT.

Wilms tumor mainly occurs in children and increase in children population is one of the factors for the growth of the wilms tumor market. The increase in prevalence and incidence of the wilms tumor is the driving factor for the wilms tumor market. For instance, the incidence of wilms tumor is 8.2 cases in one million children whose age is less than 15 years (1 case per 10,000 infants). Wilms tumor is diagnosed in the United States with 650 total cases every year. High cost of treatment and complications during and after the treatment are some of the factors which hinder the wilms tumor market growth. Late side-effects were seen in the patients with wilms tumor such as premature mortality, subsequent malignant neoplasms, congestive heart failure and end-stage renal disease.

Increase in healthcare expenditure and government support for the research and development sector in the field of cancer is the opportunity for the wilms tumor market growth. Bilateral wilms tumor is one of the challenging factors as it requires a close coordination between the researchers, oncologist, surgeons and radiologists for the wilms tumor market growth.  

This wilms tumor market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the wilms tumor treatment market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Wilms Tumor Market Scope and Market Size

The wilms tumor market is segmented on the basis of types, stages, diagnosis, treatment, end-user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of types, the wilms tumor market is segmented into favourable histology and anaplastic histology.
  • On the basis of stages, the wilms tumor market is segmented into stage I, stage II, stage III, stage IV and stage V.
  • On the basis of diagnosis, the wilms tumor market is segmented into physical examination, imaging tests and lab test. Imagining test is further segmented to ultrasound (sonogram), computed tomography (CT) scan and magnetic resonance imaging (MRI) scan. Lab test is further segmented to blood test and urine test.
  • On the basis of treatment, the wilms tumor market is segmented into surgery, chemotherapy and radiation therapy. Surgery is further segmented to radical nephrectomy and partial nephrectomy. Chemotherapy is further segmented to actinomycin D (dactinomycin), vincristine, doxorubicin (adriamycin), cyclophosphamide, etoposide, irinotecan and carboplatin.
  • On the basis of end-user, the wilms tumor market is segmented to cancer research institutes, diagnostic laboratories, hospitals and others.
  • On the basis of distribution channel, the wilms tumor market is segmented into hospital pharmacy, retail pharmacy and others.

Global Wilms Tumor Market Country Level Analysis

Global wilms tumor market is analysed and market size information is provided by country, types, stages, diagnosis, treatment, end-user and distribution channel as referenced above.

The countries covered in the wilms tumor market report are the U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

On geographical estimation, North America accounts the largest market share because of increase in incidence of patients with wilms tumor, increased healthcare expenditure and rapid awareness about the cancer among population. Middle East and Africa also shares a market share especially Africa due to increase in numbers of patients having wilms tumor.  

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

The global wilms tumor market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to global wilms tumor market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the global wilms tumor market in the growth period.

Competitive Landscape and Global Wilms Tumor Market Share Analysis

The wilms tumor market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to global Wilms tumor market.

The major players covered in the global wilms tumor market report are Merck & Co. Inc., MediLexicon International Ltd, Bristol-Myers Squibb, Bayer HealthCare LLC, APOTEX INC, Sanofi, Pasteur Inc., F Hoffmann-La Roche Ltd., Exelixis Inc, NanoSmart Pharmaceuticals Inc, Recombio SL, Selvita SA among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials